Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPO. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksShire Share News (SHP)

  • There is currently no data for SHP

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

FOREX-Dollar edges up as US yields poke above 3 percent to 4-year highs

Wed, 25th Apr 2018 04:19

* Dollar index edges up towards 4-month highs

* 10-yr US yield pokes above 3 pct for first time sinceearly 2014

* Widening yield spreads seen supporting dollar long term

* Kiwi extends drop, at its lowest since early January(Updates throughout)

By Shinichi Saoshiro

TOKYO, April 25 (Reuters) - The dollar inched up onWednesday, approaching its recent four-month high as the U.S.10-year bond yield poked above 3 percent to hit its highestlevel since early 2014.

The dollar index against a basket of six major currenciesrose 0.1 percent to 90.844. It had climbed overnight to91.016, highest since Jan. 12, before a slide in Wall Streetstocks tempered investor risk appetite and slowed thegreenback's rally against its peers, notably the yen.

The greenback had risen without pause through much of thepast week as U.S.-China trade conflict woes receded and allowedthe market to turn its attention back to dollar-supportivefundamentals, notably the surge by U.S. yields.

"Revived expectations that the U.S. economy would performwell thanks to tax cuts and increased fiscal spending aresupporting the dollar," said Shin Kadota, senior strategist atBarclays in Tokyo.

"Yields rose and equities slipped before but the situationis a little different, as expectations towards the U.S. economyare now stronger," Kadota said.

Tuesday's data on U.S. consumer confidence and new homesales, both stronger in April, bolstered the case that theworld's biggest economy will continue to grow in the comingquarters.

The U.S. currency was 0.1 percent higher at 108.900 yen. It pulled back from a 2-1/2-month high of 109.200 setthe previous day when the S&P 500 and the Dowposted their biggest declines since April 6.

While the weakening by equities was supportive for the yen,often sought when stocks fall due to its perceived safe-havenstatus, analysts said the dollar was still likely headed forfurther gains in the longer-term.

"At first glance, the situation is similar to February, whenU.S. yields rose sharply and equities tumbled. But thedifference this time is that the response by equities is moremeasured, and yen demand stemming from 'risk off' is not nearlyas strong," said Yukio Ishizuki, senior currency strategist atDaiwa Securities in Tokyo.

"The market's attention is firmly back on interest ratedifferentials and this is likely to keep supporting the dollargoing forward."

The spreads between U.S. yields and those of its Europeanand Japanese counterparts have widened significantly amiddiverging monetary policy expectations.

This week the gap between U.S. and German 10-year governmentbond yields has hit its widest in 29 years and the U.S.-Japanese10-year yield spread reached its broadest in nearly 11 years.

The 10-year Treasury yield extended itsovernight rise and touched the four-year peak of 3.009 percent,reflecting the durability of the U.S. economic expansion.Accelerating inflation and concerns about increasing debt supplyhave also driven yields higher.

Wall Street dropped sharply on Tuesday as warnings bybellwether companies of higher costs stemming from the surge inyields reverberated.

The pound was effectively flat at $1.3981. Itplumbed a one-month low of $1.3919 on Tuesday before rebounding0.3 percent, seen to have been supported in part by news about apossible takeover of British pharmaceutical company Shire Plcby Japanese drugmaker Takeda Pharmaceutical Co.

The Australian dollar shed 0.2 percent to $0.7586and in close reach of a four-month trough of $0.7576 plumbed theprevious day.

The New Zealand dollar extended losses and dipped to $0.7102, its weakest since Jan. 4.

The kiwi, on track for its seventh session of losses, hasslumped 2 percent this month.

The currency has faced pressure from a resurgent dollar andalso by increasing expectations that the Reserve Bank of NewZealand would hold off from raising rates through 2018 afterdata last week showed the country's inflation nearing the bottomof the central bank's target.(Reporting by Shinichi SaoshiroEditing by Sam Holmes)

More News
6 Sep 2019 07:54

UPDATE 1-Sumitomo Dainippon Pharma investing $3 bln in Swiss Roivant in overseas push

* Dainippon to buy 10% stake in Roivant and interests in 5 units * Schizophrenia treatment Latuda to lose US exclusivity in 2023 * Japan pharma firms grapple with declining Dainippon

Read more
14 Aug 2019 06:45

UPDATE 1-Germany's Stada 'very selective' on acquisitions - CEO Goldschmidt

FRANKFURT, Aug 14 (Reuters) - German generic drugmaker Stada will be careful about buying businesses and companies outright, and for now will focus mainly on striking production and development we

Read more
17 Jul 2019 17:55

Takeda kicks off sale of Western European drugs - sources

By Arno Schuetze and Pamela Barbaglia FRANKFURT/LONDON, July 17 (Reuters) - Japan's Takeda Pharmaceutical Co has reached out to prospective bidders for a portfolio of drugs for sale in

Read more
16 May 2019 18:35

Japan's Takeda expects binding offers for Latam business by end of May -sources

By Tatiana Bautzer SAO PAULO, May 16 (Reuters) - Japan's Takeda Pharmaceutical Co expects to receive binding offers for its Latin American business by the end of May, three sources of a

Read more
15 May 2019 08:05

Nikkei snaps 7-day losing streak helped by China's stimulus hopes

* Gains may be short-lived - analyst * Takeda Pharma, Nissan sink after earnings shock * Mitsubishi Estate jumps on share buyback, governance reform By Hideyuki Sano and Ayai

Read more
15 May 2019 04:04

Nikkei hobbled by trade worries, disappointing earnings

* Nikkei down slightly after 7 losing sessions * Uncertainties over U.S.-China standoff keep investors on edge * Takeda Pharma, Nissan sink after earnings shock * Mitsubishi -

Read more
14 May 2019 07:56

UPDATE 1-Japan's Takeda forecasts 193 bln yen annual operating loss on Shire deal

* 193 bln Y op loss forecast this yr vs 227.5 bln profit view of analysts * Shire acquisition made Takeda one of the world's most indebted drugmakers (Adds details of results, May 14 -

Read more
14 May 2019 07:39

Japan's Takeda expects annual loss on Shire deal

TOKYO, May 14 (Reuters) - Takeda Pharmaceutical Co forecast on Tuesday it would have an operating loss in the current financial year, as it books costs associated with the multibillion-dollar an a

Read more
9 May 2019 00:38

UPDATE 1-Novartis buys Takeda's dry eye drug for $3.4 bln

May 8 (Reuters) - Swiss drugmaker Novartis AG said on Wednesday it agreed to acquire Takeda Pharmaceutical Company Ltd's dry eye drug Xiidra for $3.4 billion, as well as potential milestone of

Read more
1 Feb 2019 06:07

Japan's Takeda posts 28 pct rise in Q3 operating profit

TOKYO, Feb 1 (Reuters) - Takeda Pharmaceutical Co Ltd on Friday posted a 27.9 percent rise in third-quarter operating profit, supported by strong sales of its drugs for bowel disease and multiple

Read more
22 Jan 2019 02:46

Nikkei dips as global growth concerns sap risk appetite

* IMF cuts global growth forecasts * Companies with big China exposure fall * Totech soars after raising earnings forecast By Ayai Tomisawa TOKYO, Jan 22 (Reuters) - in

Read more
8 Jan 2019 13:54

MARKET ANALYSIS: Optimism About Trade Talks May Generate Continued Buying Interest

WASHINGTON (Alliance News) - The major US index futures are pointing to a higher opening on Tuesday, with stocks likely to extend the strong upward move seen over the two previous about trade the

Read more
8 Jan 2019 08:58

Asian Shares Mixed Despite US-China Trade Deal Optimism

CANBERA (Alliance News) - Asian stocks ended mixed on Tuesday despite optimism over US-China trade talks as US officials held a second day of trade talks with Chinese counterparts in second day of

Read more
8 Jan 2019 07:39

Takeda takes control of Shire

(Sharecast News) - Takeda Pharmaceutical has taken full control of Shire after the legal particulars of its cash and share offer were completed.

Read more
7 Jan 2019 04:29

Takeda unlikely to sell OTC drug business -CEO

(Adds quote, other details) TOKYO, Jan 7 (Reuters) - Takeda Pharmaceutical is unlikely to sell its over-the-counter (OTC) drug business even amid pressure to improve its finances as it a a

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.